A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis
2010

Deferasirox for Treating Iron Overload in Hereditary Hemochromatosis

Sample size: 49 publication 10 minutes Evidence: moderate

Author Information

Author(s): Pradyumna Phatak, Pierre Brissot, Mark Wurster, Paul C Adams, Herbert L Bonkovsky, John Gross, Peter Malfertheiner, Gordon D McLaren, Claus Niederau, Alberto Piperno, Lawrie W Powell, Mark W Russo, Ulrich Stoelzel, Wolfgang Stremmel, Louis Griffel, Nicolas Lynch, Yiyun Zhang, Antonello Pietrangelo

Primary Institution: Rochester General Hospital

Hypothesis

Can deferasirox effectively reduce iron overload in patients with hereditary hemochromatosis?

Conclusion

Deferasirox doses of 5, 10, and 15 mg/kg/day can reduce iron burden in patients with hereditary hemochromatosis.

Supporting Evidence

  • Median serum ferritin levels decreased by 63.5%, 74.8%, and 74.1% in the 5, 10, and 15 mg/kg/day cohorts, respectively.
  • More patients in the 15 mg/kg/day cohort experienced increases in liver enzymes compared to lower doses.
  • Seventy-five percent of patients completed the core study, indicating good tolerability.

Takeaway

This study tested a medicine called deferasirox to help people with a condition that makes them absorb too much iron. It showed that this medicine can help lower their iron levels.

Methodology

This was an open-label, multicenter, dose-escalation study with patients receiving deferasirox at doses of 5, 10, or 15 mg/kg/day for 48 weeks.

Potential Biases

Potential conflicts of interest due to funding from Novartis and involvement of authors with the company.

Limitations

The study involved a small number of patients and many had mild iron overload.

Participant Demographics

49 Caucasian patients with hereditary hemochromatosis, predominantly male.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/hep.23879

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication